DarioHealth Corp. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
DarioHealth Corp. (DRIO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $9.10 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-11
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $11.32.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $2.29, a 57.04% decline year-over-year.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $5.33, a 28.07% decline year-over-year.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $7.41, a 65.58% decline year-over-year.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $15.38, a 832.12% increase from fiscal 2024.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $1.65, a 61.89% decline from fiscal 2023.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $4.33, a 33.38% decline from fiscal 2022.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $6.50, a 66.36% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.10 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | $11.32 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $15.38 10-K · filed 2026-03-19 | |||
| 2025-09-30 | $15.43 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $0.77 10-Q · filed 2025-08-12 | |||
| 2024-12-31 | $1.65 10-K · filed 2025-03-10 | |||
| 2024-09-30 | $1.72 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $1.93 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $2.29 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | $4.33 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $4.33 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | $4.37 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | $5.33 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $6.50 10-K · filed 2023-03-09 | |||
| 2022-09-30 | $7.02 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $7.14 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $7.41 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $19.32 10-K · filed 2022-03-22 | |||
| 2021-09-30 | $20.28 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $21.23 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | $21.53 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | $8.91 10-K · filed 2021-03-09 | |||
| 2020-09-30 | $8.42 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | $7.69 10-Q · filed 2020-08-12 | |||
| 2020-03-31 | $7.79 10-Q · filed 2020-05-12 | |||
| 2019-12-31 | $9.41 10-K · filed 2020-03-17 | |||
| 2019-09-30 | $0.70 10-Q · filed 2019-10-28 | |||
| 2019-06-30 | $0.73 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-13 | |||
| 2018-12-31 | $0.94 10-K · filed 2019-03-25 | |||
| 2017-12-31 | $1.68 10-K · filed 2018-03-19 | |||
| 2016-12-31 | $4.80 10-K · filed 2017-03-22 | |||
| 2015-12-31 | $0.33 10-K · filed 2016-02-08 | |||
| 2015-09-30 | $0.32 10-Q · filed 2015-11-13 | |||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-14 | |||
| 2014-12-31 | $6.36 10-K · filed 2015-03-24 | |||
| 2013-12-31 | $2.13 10-K · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |